FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new nitrogen-containing aromatic derivatives of the general formula:
wherein Ag represents (1) group of the formula:
; (2) group represented by the formula:
or ; (3) group represented by the formula:
; Xg represents -O-, -S-, C1-6-alkylene group or -N(Rg3)- (wherein Rg3 represents hydrogen atom); Yg represents optionally substituted C6-14-aryl group, optionally substituted 5-14-membered heterocyclic group including at least one heteroatom, such as nitrogen atom or sulfur atom, optionally substituted C1-8-alkyl group; Tg1 means (1) group represented by the following general formula:
; (2) group represented by the following general formula: . Other radical values are given in cl. 1 of the invention claim. Also, invention relates to a medicinal agent, pharmaceutical composition, angiogenesis inhibitor, method for treatment based on these compounds and to using these compounds. Invention provides preparing new compounds and medicinal agents based on thereof in aims for prophylaxis or treatment of diseases wherein inhibition of angiogenesis is effective.
EFFECT: improved treatment method, valuable medicinal properties of compounds and agents.
40 cl, 51 tbl, 741 ex
Title | Year | Author | Number |
---|---|---|---|
ANTICANCER DRUG FOR THYROID CANCER | 2007 |
|
RU2448708C2 |
AGENT FOR PROPHYLAXIS AND TREATMENT OF NEUROPATHY | 2003 |
|
RU2337682C2 |
DERIVATIVES OF 5-PYRIDYL-1,3-AZOLE, METHOD FOR THEIR PREPARING, THEIR PRODRUG, PHARMACEUTICAL COMPOSITION, METHOD FOR ANTAGONISM OF ADENOSINE A3-RECEPTOR, METHOD FOR INHIBITION OF P38 MAP KINASE, METHOD FOR INHIBITION PRODUCING TNF-ALPHA AND METHOD FOR PROPHYLAXIS | 2000 |
|
RU2237062C2 |
TABLET CONTAINING SPARINGLY SOLUBLE ACTIVE INGREDIENT | 2006 |
|
RU2420278C2 |
HETEROCYCLIC COMPOUND | 2018 |
|
RU2791533C2 |
PYRIDIN DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | 2004 |
|
RU2353617C2 |
HETEROCYCLIC COMPOUND | 2019 |
|
RU2806347C2 |
DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 | 2010 |
|
RU2536102C2 |
PHARMACEUTICAL COMPOUNDS | 2015 |
|
RU2687060C2 |
NEW P2X7 RECEPTOR ANTAGONISTS, METHOD OF OBTAINING THEM, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USE, BASED ON ANTAGONISTS | 2004 |
|
RU2347778C2 |
Authors
Dates
2005-11-20—Published
2001-10-19—Filed